RSI Overbought Stocks
ASTH is RSI overbought, meaning strong buying pressure may lead to a short-term consolidation or pullback.
ASTRANA HEALTH INC (ASTH) Stock Price & Overview
NASDAQ:ASTH • US03763A2078
Current stock price
34.89 USD
+0.75 (+2.2%)
At close:
34.89 USD
0 (0%)
After Hours:
The current stock price of ASTH is 34.89 USD. Today ASTH is up by 2.2%. In the past month the price increased by 39.28%. In the past year, price increased by 7.39%.
ASTH Key Statistics
52-Week Range18.08 - 35.375
Current ASTH stock price positioned within its 52-week range.
1-Month Range24.87 - 35.375
Current ASTH stock price positioned within its 1-month range.
- Market Cap
- 1.726B
- P/E
- 75.85
- Fwd P/E
- 27.71
- EPS (TTM)
- 0.46
- Dividend Yield
- N/A
ASTH Stock Performance
Today
+2.2%
1 Week
+3.47%
1 Month
+39.28%
3 Months
+53.43%
Longer-term
6 Months +11.79%
1 Year +7.39%
2 Years -15.79%
3 Years N/A
5 Years N/A
10 Years N/A
ASTH Stock Chart
ASTH Stock Screens
ASTH currently appears in the following ChartMill screener lists.
ASTH Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ASTH. When comparing the yearly performance of all stocks, ASTH is one of the better performing stocks in the market, outperforming 83.57% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
ASTH Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ASTH. Both the profitability and financial health of ASTH have multiple concerns.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ASTH Earnings
On March 2, 2026 ASTH reported an EPS of 0.12 and a revenue of 950.53M. The company beat EPS expectations (10.99% surprise) and beat revenue expectations (0.15% surprise).
Next Earnings DateMay 7, 2026
Last Earnings DateMar 2, 2026
PeriodQ4 / 2025
EPS Reported$0.12
Revenue Reported950.526M
EPS Surprise 10.99%
Revenue Surprise 0.15%
ASTH Forecast & Estimates
17 analysts have analysed ASTH and the average price target is 36.72 USD. This implies a price increase of 5.25% is expected in the next year compared to the current price of 34.89.
For the next year, analysts expect an EPS growth of 173.72% and a revenue growth 25.71% for ASTH
Analysts
Analysts84.71
Price Target36.72 (5.25%)
EPS Next Y173.72%
Revenue Next Year25.71%
ASTH Index Membership
ASTH is currently included in the following stock indexes tracked on ChartMill.
ASTH Financial Highlights
Over the last trailing twelve months ASTH reported a non-GAAP Earnings per Share(EPS) of 0.46. The EPS decreased by -48.31% compared to the year before.
Income Statements
Revenue(TTM)3.18B
Net Income(TTM)22.49M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.71% | ||
| ROA | 1.01% | ||
| ROE | 2.89% | ||
| Debt/Equity | 1.27 |
Chartmill High Growth Momentum
EPS Q2Q%180%
Sales Q2Q%42.89%
EPS 1Y (TTM)-48.31%
Revenue 1Y (TTM)56.39%
ASTH Ownership
Ownership
Inst Owners60.09%
Shares49.47M
Float38.05M
Ins Owners9.93%
Short Float %7.06%
Short Ratio5.57
ASTH Industry Overview
ASTH operates in the Health Care Services sub-industry within the Health Care sector. This group contains 51 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Strength Score
49/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
Industry Growth Score
87/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
55%
Outperformed 55% of sub-industries
3 Month Rank
62%
Outperformed 62% of sub-industries
6 Month Rank
48%
Outperformed 48% of sub-industries
Industry Fundamentals & Breadth
- Members
- 51
- New Highs
- 9.8%
- New Lows
- 5.9%
- Average ROE
- 10%
- Average Profit Margin
- 2.8%
- Average Operating Margin
- 5.2%
- Average P/E
- 41.9
- Average Fwd P/E
- 27.3
- Average Debt/Equity
- 0.8
ASTH Competitors/Peers
The largest stocks on the US markets in the "Health Care Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.34 | 106.744B | ||
| CI | THE CIGNA GROUP | 8.22 | 76.614B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 109.63 | 30.529B | ||
| DGX | QUEST DIAGNOSTICS INC | 16.67 | 21.494B | ||
| LH | LABCORP HOLDINGS INC | 12.87 | 21.106B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.422B | ||
| DVA | DAVITA INC | 10.74 | 10.363B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 33.1 | 9.266B | ||
| CHE | CHEMED CORP | 15.7 | 6.209B | ||
| HIMS | HIMS & HERS HEALTH INC | 47.14 | 6.193B | ||
| RDNT | RADNET INC | 86.89 | 4.389B | ||
| HNGE | HINGE HEALTH INC-A | 23.53 | 3.513B | ||
| BLLN | BILLIONTOONE INC CL A | 159.08 | 3.45B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ASTH
Company Profile
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 3,000 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.
Company Info
IPO: 1999-04-09
ASTRANA HEALTH INC
1668 S. Garfield Avenue, 2Nd Floor
Alhambra CALIFORNIA US
Employees: 3000
Phone: 16262820288
ASTRANA HEALTH INC / ASTH FAQ
Can you describe the business of ASTRANA HEALTH INC?
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 3,000 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.
What is the stock price of ASTRANA HEALTH INC today?
The current stock price of ASTH is 34.89 USD. The price increased by 2.2% in the last trading session.
What is the dividend status of ASTRANA HEALTH INC?
ASTH does not pay a dividend.
How is the ChartMill rating for ASTRANA HEALTH INC?
ASTH has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is ASTRANA HEALTH INC (ASTH) stock traded?
ASTH stock is listed on the Nasdaq exchange.
How is the market expecting ASTH stock to perform?
17 analysts have analysed ASTH and the average price target is 36.72 USD. This implies a price increase of 5.25% is expected in the next year compared to the current price of 34.89.
Should I buy ASTH stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ASTH.